Neuroene Therapeutics

Manufacturing · South Carolina, United States · 1-10 Employees

View Company Info for Free

Overview

Headquarters

645 Meeting St Ste 201I, Charleston, Sou...

Revenue

$5.9 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1

About Neuroene Therapeutics

Neuroene Therapeutics specializes in developing innovative treatments for neurological diseases, focusing on conditions such as medication-resistant epilepsy, Parkinson's disease, and rare mitochondrial disorders. The company offers patented medications that utilize proprietary Vitamin K analogs, which are designed to be orally bioavailable and effectively penetrate the brain. Their approach addresses mitochondrial dysfunction, a common factor in many neurological diseases, highlighting the critical need for new therapeutic options. With a highly recognized management and advisory team, Neuroene Therapeutics aims to meet the significant unmet needs in the field of neurological disease treatment.Explore more
Neuroene Therapeutics's Social MediaPopular SearchesNeuroene TherapeuticsNeuroene Therapeutics IncNeuroenetherapeuticsSIC Code 28,283NAICS Code 32,325Show more

Neuroene Therapeutics Org Chart

PhoneEmail
RH
United States flag for contact location.

Chief Scientific Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Neuroene Therapeutics your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Neuroene Therapeutics

Compare insights from companies similar to Neuroene Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Neuroene Therapeutics

$5.9M
1-10
Private
-
1824
RH
Richard HimesChief Scientific Officer
$6.3M
1-10
Private
$6M
2019
<$5M
11-50
Public
-
2006
Terrie Kellmeyer, Interim Chief Executive Officer at Anavex Life Sciences
Terrie KellmeyerInterim CEO
<$5M
11-50
Private
$37M
2011
N/A
<$5M
11-50
Private
$5.8M
2016
<$5M
1-10
Private
$10.3M
2005
FL
Frank LongoCo-Founder
Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Neuroene Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Neuroene Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Neuroene Therapeutics.

Neuroene Therapeutics Tech Stack

A closer look at the technologies used by Neuroene Therapeutics

Neuroene Therapeutics News & Media

Read more news

Top Manufacturing Companies

Frequently Asked Questions Regarding Neuroene Therapeutics

What is Neuroene Therapeutics's official website?
Neuroene Therapeutics's official website is www.neuroenetherapeutics.com
What is Neuroene Therapeutics's Revenue?
Neuroene Therapeutics's revenue is $5.9 Million
What is Neuroene Therapeutics's SIC code?
Neuroene Therapeutics's SIC: 28,283
What is Neuroene Therapeutics's NAICS code?
Neuroene Therapeutics's NAICS: 32,325
How many employees does Neuroene Therapeutics have?
Neuroene Therapeutics has 1-10 employees
What industry does Neuroene Therapeutics belong to?
Neuroene Therapeutics is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is Neuroene Therapeutics competition?
Neuroene Therapeutics top competitors include: Collaborative Medicinal Development, Anavex Life Sciences, KeifeRx, Lysosomal Therapeutics
What technology does Neuroene Therapeutics use?
Some of the popular technologies that Neuroene Therapeutics uses are: WordPress.org, PHP, Cloudflare Website Optimization, Cloudflare CDN
What does Neuroene Therapeutics do?

Neuroene Therapeutics specializes in developing innovative treatments for neurological diseases, focusing on conditions such as medication-resistant epilepsy, Parkinson's disease, and rare mitochondrial disorders. The company offers patented medications that utilize proprietary Vitamin K analogs, which are designed to be orally bioavailable and eff... ectively penetrate the brain. Their approach addresses mitochondrial dysfunction, a common factor in many neurological diseases, highlighting the critical need for new therapeutic options. With a highly recognized management and advisory team, Neuroene Therapeutics aims to meet the significant unmet needs in the field of neurological disease treatment.Read More

What are Neuroene Therapeutics social media links?
Neuroene Therapeutics Linkedin page
Is Neuroene Therapeutics a public company?
Neuroene Therapeutics is private company therefore does not currently have an official ticker symbol
See more information about Neuroene Therapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.